Lacosamide 10mg/ml : Presence of particulate matter in affected lot.
Brand(s)
Last updated
Summary
Product
Lacosamide Injection 10mg/ml
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
---|---|---|---|---|---|
LACOSAMIDE INJECTION, USP |
LACOSAMIDE INJECTION, USP |
DIN 02541343 |
Solution |
LACOSAMIDE 10mg/mL |
2302208.1 |
Issue
Presence of particulate matter in affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Health Care Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Hikma Canada Limited 5995 Avenbury Road, Suite 804, Mississauga, Ontario L5R 3P9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-76893
Get notified
Receive notifications for new and updated recalls and alerts by category.